Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research note released on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock Performance Shares of PULM opened at $1.88 on Friday. Pulmatrix has a twelve month low of $1.55 and a twelve month high of […]